— Know what they know.
Not Investment Advice
Also trades as: AYR-A.CN (CNQ) · $vol 0M

AYRWF OTC

Ayr Wellness Inc.
1W: +0.0% 1M: +0.0% 3M: -75.3% YTD: -82.6% 1Y: -84.9% 3Y: -99.9% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 52 · $432062 mcap · 93M float · 0.202% daily turnover · Short 27% of daily vol

Income Trends

Revenue
$464M +0.0% ▲
5Y CAGR: +43.9%
Gross Profit
$177M -12.7% ▼
5Y CAGR: +46.4%
Operating Income
-$161M -332.6% ▼
Net Income
-$359M -31.9% ▼
EPS (Diluted)
$-3.24 +12.0% ▲
EBITDA
-$155M -279.4% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$155M$358M$421M$464M$464M
YoY Growth+106.3%+130.5%+17.8%+10.0%+0.0%
Cost of Revenue$52M$220M$275M$261M$287M
Gross Profit$89M$138M$181M$202M$177M
Gross Margin57.2%38.6%43.0%43.7%38.1%
R&D Expenses$0$0$0$0$0
SG&A Expenses$72M$144M$222M$178M$167M
Operating Expenses$88M$194M$388M$240M$338M
Operating Income$1M-$56M-$207M-$37M-$161M
Operating Margin0.8%-15.7%-49.2%-8.0%-34.7%
Interest Expense$3M$17M$28M$39M$78M
Income Before Tax-$3M$12M-$172M-$46M-$319M
Tax Expense$22M$29M$45M$47M$43M
Net Income-$25M-$17M-$245M-$272M-$359M
Net Margin-15.9%-4.7%-58.2%-58.8%-77.5%
EPS (Diluted)$-0.88$-0.29$-3.43$-3.68$-3.24
EBITDA$21M$88M-$993K$86M-$155M
Shares Outstanding28M57M69M74M111M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms